Benzinga's Volume Movers

shares rose 10.73 percent to $12.07. The volume of Flexion Therapeutics shares traded was 2703 percent higher than normal. Flexion Therapeutics reported that the Phase 3 clinical trial for Zilretta met its primary endpoint in knee osteoarthritis.

shares climbed 10.05 percent to $22.56. The volume of Shopify shares traded was 1133 percent higher than normal. Shopify reported better-than-expected Q4 results.

shares moved up 28.61 percent to $44.32. The volume of Fossil Group traded was 593 percent higher than normal. Fossil Group reported stronger-than-expected results for its fourth quarter on Tuesday.

surged 11.46 percent to $1,238.00. The volume of Priceline Group shares traded was 411 percent higher than normal. Priceline reported better-than-expected results for its fourth quarter.